Introduction {#s1}
============

Association mapping refers to the linking of genotypes to phenotypes. Most often this is done using a genome-wide association study (GWAS) with single nucleotide polymorphisms (SNPs). Individuals are genotyped at a set of known SNP locations using a SNP array. Then each SNP is tested for statistically significant association with the phenotype. In recent years thousands of genome-wide association studies have been performed and regions associated with traits and diseases have been located.

However, this approach has a number of limitations. First, designing SNP arrays requires knowledge about the genome of the organism and where the SNPs are located in the genome. This makes it hard to apply to study organisms other than human. Even the human reference genome was shown to be incomplete ([@bib2]) and association mapping to regions not in the reference is difficult. Second, structural variations such as insertion-deletions (indels) and copy number variations are usually ignored in these studies. Despite the many GWA studies that have been performed a significant amount of heritability is yet to be explained. This is known as the 'missing heritability' problem ([@bib51]). A hypothesis is some of the missing heritability is due to structural variations. Third, the phenotype might be caused by rare variants which are not on the SNP chip. In last two cases, follow up work is required to find the causal variant even if association is detected in the GWAS.

Some of these limitations can be overcome by utilizing high throughput sequencing data. As sequencing gets cheaper association mapping using next generation sequencing is becoming feasible. The current approach to doing this is to map all the reads to a reference genome followed by variant calling. Then these variants can be tested for association. But this again requires a reference genome and it may induce biases in variant calling and regions not in the reference genome will not be included in the study. Moreover, sequencing errors make genotype calling difficult when sequencing depth is low ([@bib31]) and in repetitive regions. Methods have been proposed to do population genetics analyses that avoid the genotype calling step ([@bib8], [@bib9]) but these methods still require reads to be aligned to a reference genome. An alternate approach is simultaneous de novo assembly and genotyping using a tool such as Cortex ([@bib17]) but this is not suited to large number of individuals as simultaneous assembly and variant calling need loading all $k$-mers from all samples into memory requiring large amount of it. The alternative approach of loading a subset of samples to process at a time would require subsequent alignment of sequences. Neither of these approaches is trivially parallelizable.

In the past, alignment free methods have been developed for a number of problems including transcript abundance estimation ([@bib33]), sequence comparison ([@bib44]), phylogeny estimation ([@bib13]), etc. ([@bib32]) introduced a pipeline called needle in the $k$-stack (NIKS) for mutation identification by comparison of sequencing data from two strains using $k$-mers. ([@bib42]) presented a method for association mapping in bacterial genomes using $k$-mers. More recently, ([@bib7]) proposed a method for mapping associations to lineages when associations can not be accurately mapped to loci and ([@bib26]) showed that use of variable length $k$-mers leads to an increase in power.

However, these methods for association mapping in bacterial genomes use only the presence and absence of $k$-mers and ignore the actual counts. This prevents association mapping to copy number variations (CNVs). Moreover, tests based on $k$-mer counts are likely to have more power, making detection of association with smaller number of samples possible ([Appendix 1---figures 2](#app1fig1){ref-type="fig"} and [3](#app1fig2){ref-type="fig"}). Here we present an alignment free method for association mapping to categorical phenotypes. It is based on counting $k$-mers and identifying $k$-mers associated with the phenotype. The overlapping $k$-mers found are then assembled to obtain sequences corresponding to associated regions. Our method is applicable to association studies in organisms with no or incomplete reference genome. Even if a reference genome is available, this method has the advantage of avoiding aligning and genotype calling thus allowing association mapping to many types of variants using the same pipeline and to regions not in the reference.

In contrast to the approach in [@bib17], in our method, $k$-mers are initially tested for association independently of other $k$-mers allowing us to load only a subset of $k$-mers using lexicographic ordering. However, their approach can utilize information from the reference genome if one is available whereas we currently make use of the reference genome only after sequences associated have been obtained to determine the type of associated variant. A future direction may be to utilize this information earlier in the pipeline.

We have implemented our method in a software called 'hitting associations with $k$-mers' (HAWK). Experiments with simulated and real data demonstrate the promises of this approach. To test our approach in a setting not confounded by population structure, we apply our method to analyze whole genome sequencing data from three populations in the 1000 genomes project treating population identity as the trait of interest.

In a pairwise comparison of the Toscani in Italia (TSI) and the Yoruba in Ibadan, Nigeria (YRI) populations we find that sequences identified by our method largely agree with results obtained using standard GWAS based on variant calling from mapped reads (Figure 2). Agreement with sites found using read alignment and genotype calling indicate that $k$-mer based association mapping will be applicable to mapping associations to diseases and traits.

We also analyze data from the Bengali from Bangladesh (BEB) population to explore possible genetic basis of high rate of mortality due to cardiovascular diseases (CVD) among South Asians and find significant differences in frequencies of a number of non-synonymous variants in genes linked to CVDs between BEB and TSI samples, including the site rs1042034, which has been associated with higher risk of CVDs previously, and the nearby rs676210 in the *Apolipoprotein B (ApoB)* gene.

We then demonstrate that population structure can be inferred from $k$-mer data from whole genome sequencing reads and discuss how population stratification and other confounders can be accounted for. Finally, we apply our method to *E. coli* data set on ampicillin resistance and find hits to the $\beta$*-lactamase TEM (blaTEM)* gene, the presence of which is known to confer ampicillin resistance, validating our overall approach.

Materials and methods {#s2}
=====================

Association mapping with $k$-mers {#s2-1}
---------------------------------

We present a method for finding regions associated with a categorical trait using sequencing reads without mapping reads to reference genomes. The workflow is illustrated in [Figure 1](#fig1){ref-type="fig"}. Given whole genome sequencing reads from case and control samples, we count $k$-mers appearing in each sample. We assume the counts are Poisson distributed and test $k$-mers for statistically significant association with case or control using likelihood ratio test for nested models (see Appendix 1 for details). Population structure is then inferred from $k$-mer data and used to adjust p-values. The differences in $k$-mer counts may be due to single nucleotide polymorphisms (SNPs), insertion-deletions (indels) and copy number variations. The $k$-mers are then assembled to obtain sequences corresponding to each region.

![Workflow for association mapping using $k$-mers.\
The [Hawk]{.smallcaps} pipeline starts with sequencing reads from two sets of samples. The first step is to count $k$-mers in reads from each sample. Then $k$-mers with significantly different counts in two sets are detected. Finally, overlapping $k$-mers are assembled into sequences to get a sequence, shown side by side, for each associated locus. The sequences may correspond to a SNP (underlined) in which case corresponding sequence may be detected in the other group. This may not be the case for other kinds of variations such as copy number variation.](elife-32920-fig1){#fig1}

Counting $k$-mers {#s2-2}
-----------------

The first step in our method for association mapping from sequencing reads using $k$-mers is to count $k$-mers in sequencing reads from all samples. To count $k$-mers we use the multi-threaded hash based tool [Jellyfish]{.smallcaps} ([@bib29]). However, the pipeline can be modified to work with any $k$-mer counting tool. We use $k$-mers of length 31 which is the longest $k$-mer length which can be efficiently represented on 64-bit machines using [Jellyfish]{.smallcaps} and filter out $k$-mers that appear once in samples before testing for associations for computational and memory efficiency as they are likely from sequencing errors.

Finding significant $k$-mers {#s2-3}
----------------------------

Then for each $k$-mer we test whether that $k$-mer appears significantly more times in case or control datasets compared to the other using a likelihood ratio test for nested models ([@bib48]). Suppose, the reads are of length $l$, then we observe a $k$-mer if a read starts in one of $l - k + 1$ positions at the start of the $k$-mer in the genome or preceding it. So, the count of a $k$-mer equals the number of reads that start in $l - k + 1$ positions, the probability of which is small for most $k$-mers as genomes tend to be much longer compared to that segment. That combined with the large number of reads in second generation sequencing motivates us to assume Poisson distributions which allows us to compute p-values quickly compared to negative binomial distributions used to model RNA-seq data ([@bib39]; [@bib46]). Furthermore, we observe that for large number of $k$-mers in a whole genome sequencing experiment and typical counts of a single $k$-mer, p-values calculated assuming Poisson distributions are not notably lower than those obtained assuming negative binomial distributions ([Appendix 1---figure 1](#app1fig1){ref-type="fig"}).

Suppose, a particular $k$-mer appears $K_{1}$ times in cases and $K_{2}$ times in controls, and $N_{1}$ and $N_{2}$ are the total number of $k$-mers in cases and controls respectively. The $k$-mer counts are assumed to be Poisson distributed with rates $\theta_{1}$ and $\theta_{2}$ in cases and controls. The null hypothesis is $H_{0}:\theta_{1} = \theta_{2} = \theta$ and the alternate hypothesis is $H_{1}:\theta_{1} \neq \theta_{2}$. The likelihoods under the alternate and the null are given by (see Appendix 1 for details)$$L\left( \theta_{1},\theta_{2} \right) = \frac{e^{- \theta_{1}N_{1}}\left( \theta_{1}N_{1} \right)^{K_{1}}}{K_{1}!}\frac{e^{- \theta_{2}N_{2}}\left( \theta_{2}N_{2} \right)^{K_{2}}}{K_{2}!}$$and$$L\left( \theta \right) = \frac{e^{- \theta N_{1}}\left( \theta N_{1} \right)^{K_{1}}}{K_{1}!}\frac{e^{- \theta N_{2}}\left( \theta N_{2} \right)^{K_{2}}}{K_{2}!}.$$

Since the null model is a special case of the alternate model, $2ln\Lambda$ is approximately chi-squared distributed with one degree of freedom where $\Lambda$ is the likelihood ratio. We get a p-value for each $k$-mer using the approximate $\chi^{2}$ distribution of the likelihood ratio and perform Bonferroni corrections to account for multiple testing. We use the conservative Bonferroni correction as deviations from Poisson distributions are possible.

Our approach may be extended to quantitative phenotypes, by regressing phenotype values against $k$-mer counts to test whether $k$-mer counts are predictive of the phenotype.

Detecting population structure {#s2-4}
------------------------------

To detect population structure in the data, we randomly choose one-thousandth of the $k$-mers present between 1% and 99% of the samples and construct a binary matrix $B = \left\{ b_{ij} \right\}$ where $b_{ij} = 1$ if the $j$-th $k$-mer is present in the $i$-th individual and $0$ otherwise. We then perform principal components analysis (PCA) on the matrix which has been widely used to uncover population structure in genotype data ([@bib34]; [@bib35]). We have modified the [Eigenstrat]{.smallcaps} software ([@bib34]) to run PCA on $B$ and as in [Eigenstrat]{.smallcaps}, we normalize values in the $j$-th column using$$m_{ij} = \frac{b_{ij} - \mu_{j}}{\sqrt{p_{j}\left( 1 - p_{j} \right)}}$$so that columns have approximately the same variance. Here $\mu_{j}$ is the mean of the $j$-th column and $p_{j}$ is the allele frequency estimated from the fraction of samples with the corresponding $k$-mer using the formula $p_{j} = 1 - \sqrt{1 - \mu_{j}}$ for diploids and $p_{j} = \mu_{j}$ for haploid organisms.

Correcting for population stratification and other confounders {#s2-5}
--------------------------------------------------------------

Population stratification is a known confounder in association studies. In association mapping from sequencing reads other possible confounding factors include variations in sequencing depth and batch effects. To correct for confounders in association mapping involving a categorical phenotype, for the $k$-mers found significant in the Poisson distribution based likelihood ratio test, we fit a logistic regression model on the phenotype against potential confounders and $k$-mer counts normalized using total number of $k$-mers in the sample. By default we include first two principal components obtained in the previous step and total number of $k$-mers in sequencing reads from each individual to account for population structure and varying sequencing depth respectively but other potential confounders may also be included as needed.

We then quantify the additional goodness of fit provided by each $k$-mer after the confounding factors and use R script to obtain an ANOVA p-value using a $\chi^{2}$-test with likelihood ratio and apply Bonferroni threshold established earlier. That is a logistic regression model is fitted against the confounders and probability of responses are used to compute likelihood. Similarly, another logistic regression model is fitted against the confounders as well as $k$-mer counts and likelihood under this model is computed. Since the former model is a special case of the latter, negative logarithm of the likelihood ratio is asymptotically $\chi^{2}$ distributed with one degree of freedom which is then used to calculate a p-value. For quantitative phenotypes linear regression may be used instead of logistic regression.

We performed simulations to compare powers of Poisson distribution based likelihood ratio test and logistic regression based tests to detect association for different coverages and varying number of case individuals having one and two copies of the allele with number of copies in control individuals fixed at zero and one copy respectively. The results are shown in [Appendix 1---figure 4](#app1fig4){ref-type="fig"}. We observe that logistic regression based tests have less power compared to Poisson distribution based test. We also note that logistic regression based test using only presence and absence of $k$-mer has similar power as the one using $k$-mer counts while detecting one copy of an allele against zero copies but it is unable to detect association if cases have two copies of an allele against one copy in controls. We leave designing tests modeling stochasticity in counts incorporating confounders as well as extending our approach to quantitative phenotypes as future work.

Merging $k$-mers {#s2-6}
----------------

We then take $k$-mers associated with cases and controls and locally assemble overlapping $k$-mers to get a sequence for each differential site using the assembler ABySS ([@bib43]). The goal of this step is to have a sequences for each associated locus instead of having multiple $k$-mers from it. ABySS was used as the assemblies it generated were found to cover more of the sequences to be assembled compared to other assemblers ([@bib37]). We construct the de Bruijn graph using hash length of 25 to be robust to lack of detection of some 31-mers without creating many ambiguous paths in the de Bruijn graph and retain assembled sequences of length at least 49 which is the length formed by 25-mers overlapping with a SNP site on either side. It is also possible to merge $k$-mers and pair corresponding sequences from cases and controls using the NIKS pipeline (see \[[@bib32]\] for details). However, we find that this is time consuming when we have many significant $k$-mers. Moreover, when number of cases and controls are not very high we do not have enough power to get both of the sequences to be paired and as such pairing is not possible.

Implementation {#s2-7}
--------------

Our method is implemented in a tool called 'hitting associations with $k$-mers' (HAWK) using C++. To speed up the computation we use a multi-threaded implementation. In addition, it is not possible to load all the $k$-mers into memory at the same time for large genomes. So, we sort the $k$-mers lexicographically and load them into memory in batches. To make the sorting faster [Jellyfish]{.smallcaps} has been modified to output integer representation of $k$-mers instead of the $k$-mer strings. In future the sorting step may be avoided by utilizing the internal ordering of [Jellyfish]{.smallcaps} or other tools for $k$-mer counting. The principal components analysis (PCA) is performed using a modified version of the widely used [Eigenstrat]{.smallcaps} software ([@bib34]). The logistic regression model fitting and p-value computation is done using scripts written in R and we are presently exploring ways to speed up the computation. The implementation is available at <http://atifrahman.github.io/HAWK/> (copy archived at <https://github.com/elifesciences-publications/HAWK>).

Downstream analysis {#s2-8}
-------------------

The sequences obtained by merging overlapping $k$-mers can then be analyzed by aligning to a reference if one is available or by running BLAST ([@bib3]) to check for hits to related organisms. The intersection results in this paper were obtained by mapping them to the human reference genome version GRCh37 using Bowtie2 ([@bib25]) to be consistent with co-ordinates of genoptypes called by 1000 genomes project. The breakdown analysis was performed by first mapping to the version of the human reference genome at the UCSC Human Genome Browser, hg38 and then running BLAST on some of the ones that did not map. Specific loci of interest were checked by aligning them to RefSeq mRNAs using Bowtie2 and on the UCSC Human Genome Browser by running BLAT ([@bib22]).

Results {#s3}
=======

Verification with simulated data {#s3-1}
--------------------------------

The implementation was tested by simulating reads from the genome of an *Escherichia coli* strain. We introduced different types mutations - single nucleotide changes, short indels (less than 10 bp) and long indels (between 100 bp and 1000 bp) into the genome. Then wgsim of SAM tools ([@bib27]) was used to first generate two sets of genomes by introducing additional random mutations (both substitutions and indels) into the original and the modified genomes and then simulate reads with sequencing error rate of 1% and other default parameters of wgsim. The [Hawk]{.smallcaps} pipeline was then run on these two sets of sequencing reads. The fraction of mutations covered by resulting sequences are shown in [Appendix 1---figure 5](#app1fig5){ref-type="fig"} for varying numbers of case and control samples and different types of mutations. The results are consistent with calculation of power to detect $k$-mers for varying total $k$-mer coverage ([Appendix 1---figure 2](#app1fig2){ref-type="fig"}) with slightly lower values expected due to sequencing errors and conditions imposed during assembly.

Verification with 1000 genomes data {#s3-2}
-----------------------------------

To analyze the performance of the method on real data we used sequencing reads from the 1000 genomes project ([@bib1]). The population identities were used as the phenotype of interest circumventing the need for correction of population structure. For verification, we used sequencing reads from 87 YRI individuals and 98 TSI individuals for which both sequencing reads and genotype calls were available at the time analysis was performed. The genotype calling was performed using the same set of reads we used to perform association mapping.

The analysis using $k$-mers revealed 2,970,929 sequences enriched for in the YRI population as compared to the TSI population and 1,865,285 sequences enriched for in TSI samples. QQ plot of the p-values obtained is shown in [Appendix 1---figure 6(a)](#app1fig6){ref-type="fig"}. Although we observe large deviations from the diagonal line, this is partly due to large number of $k$-mers for which the null is not true and cumulative distribution of the p-values, shown in [Appendix 1---figure 6(b)](#app1fig6){ref-type="fig"}, reveals that majority of the p-values are not significantly small.

To compare the results with the standard approach of mapping reads and calling variants, we also performed similar analysis with genotype calls available from the 1000 genomes project. VCFtools ([@bib6]) was used to obtain number of individuals with 0, 1 and 2 copies of one of the alleles for each SNP site. Each site was then tested to check whether the allele frequencies are significantly different in two samples using likelihood ratio test for nested models for multinomial distribution (details in Appendix 1). We found that 2,658,964 out of the 39,706,715 sites had allele frequencies that are significantly different.

[Figure 2a](#fig2){ref-type="fig"} shows the extent of overlap among these discarding the sequences that did not map to the reference. We used to BEDtools ([@bib36]) to determine the number sites that were within an interval covered by at least one sequence found by assembling $k$-mers. We find that $80.3\%$ (2,135,415 out of 2,658,964) of the significant sites was covered by some sequence found using [Hawk]{.smallcaps} while $19.7\%$ was not as shown in the Venn diagram on the top left. Approximately $95.2\%$ of the sites was covered by at least one $k$-mer.

![Intersection analysis and comparison of powers of tests.\
(**a**) Venn diagrams showing intersections among sequences obtained using [Hawk]{.smallcaps} and significant sites found by genotype calling. The percentage values shown are fractions of the sites found using one method not covered by those found by the other method. $80.3\%$ of the sites overlapped with some sequence. Around $42\%$ of sequences do not overlap with any such site which can be explained by more types of variants found by [Hawk]{.smallcaps} as well as more power of the test using Poisson compared to Multinomial distribution. (**b**) Fraction of runs found significant (after Bonferroni correction) by tests against minor allele frequency of the case samples (with that of the controls fixed at 0) are shown. The curves labeled multinomial and Poisson correspond to likelihood ratio test using multinomial distribution and Poisson distributions with different $k$-mer coverage.](elife-32920-fig2){#fig2}

We also observe that around $42\%$ of sequences found using $k$-mers do not cover any sites found significant using genotype calling. While up to $20\%$ of them correspond to regions for which we did not have genotype calls (chromosome Y, mitochondrial DNA and small contigs), repetitive regions where genotype calling is difficult and structural variations, many of the remaining sequences are possibly due to more power of the test based on counts than the one using only number of copies of an allele. We performed Monte Carlo simulations to determine powers of the two tests. [Figure 2(b)](#fig2){ref-type="fig"} shows the fraction of trials that passed the p-value threshold after Bonferroni correction as the allele frequencies in cases were increased keeping the allele frequencies of control fixed at 0.

This is consistent with greater fraction of sequences in YRI ($47.3\%$ shown in bottom left of [Figure 2(a)](#fig2){ref-type="fig"}) not covering sites obtained by genotyping compared to TSI ($38.7\%$ shown in bottom right of [Figure 2(a)](#fig2){ref-type="fig"}) as some low frequency variations in African populations were lost in other populations due to population bottleneck during the migration out of Africa. However, some false positives may result due to discrepancies in sequencing depth of the samples and sequencing biases. We provide scripts to lookup number of individuals with constituent $k$-mers to help investigate sites found using Poisson distribution based likelihood ratio test only. [Table 1](#table1){ref-type="table"} shows example p-values of some of the well known sites of variation between African and European populations as well as fraction of individuals in each group with the variant looked up using such scripts.

10.7554/eLife.32920.004

###### Known variants in YRI-TSI comparison.

[Table 1](#table1){ref-type="table"} shows p-values of sequences computed using likelihood ratio test at some well known sites of variation between populations. The (%) values denote fraction of individuals in the sample with the allele present. The p-values and % values are averaged over $k$-mers constituting the associated sequences.

  Gene      SNP id       Description         Allele   p-value                   %YRI     %TSI
  --------- ------------ ------------------- -------- ------------------------- -------- -------
  ACKR1     rs2814778    Duffy antigen       C        9.72$\times 10^{- 114}$   84.39%   1.78%
  SLC24A5   rs1426654    Skin pigmentation   G        8.45$\times 10^{- 144}$   87.39%   1.02%
  SLC45A2   rs16891982   Skin/hair color     C        1.89$\times 10^{- 122}$   92.18%   4.67%
  G6PD      rs1050829    G6PD deficiency     C        1.53$\times 10^{- 29}$    24.92%   1.02%
  G6PD      rs1050828    G6PD deficiency     T        5.83$\times 10^{- 25}$    18.32%   0.00%

HAWK maps associations to multiple variant types {#s3-3}
------------------------------------------------

[Hawk]{.smallcaps} enables mapping associations to different types of variants using the same pipeline. [Figure 3(a)](#fig3){ref-type="fig"} shows breakdown of types of variants found associated with YRI and TSI populations. The 'Multiple SNPs/Structural' entries correspond to sequences of length greater than 61 (the maximum length of a sequence due to a single SNP with $k$-mer size of 31 as 31-mers covering the SNP can extend to a maximum of 30 bases on either side of the SNP). In addition to SNPs we find associations to sites with indels and structural variations. Furthermore, we find sequences that map to multiple regions in the genome indicating copy number variations or sequence variation in repeated regions where genotype calling is known to be difficult. Although the majority of the sequences map outside of genes, we find variants in genes including in coding regions ([Figure 3(b)](#fig3){ref-type="fig"}).

![Breakdown of types of variations in comparison of YRI-TSI.\
(**a**) Bars showing breakdown of 2,970,929 and 1,865,285 sequences enriched for in YRI and TSI samples respectively. The 'Multiple SNPs/Structural' entries correspond to sequences of length greater than 61, the maximum length of a sequence due to a single SNP with $k$-mer size of 31 and 'SNPs' correspond to sequences of maximum length of 61. (**b**) Numbers of sequences with alignments to hg38, RefSeq mRNAs and Ensembl exons and coding regions.](elife-32920-fig3){#fig3}

We performed similar analysis on sequencing reads available from 87 BEB and 110 TSI individuals from the 1000 genomes project and obtained 529,287 and 462,122 sequences associated with BEB and TSI samples respectively, much fewer than the YRI-TSI comparison. [Appendix 1---figure 7](#app1fig7){ref-type="fig"} shows breakdown of probable variant types corresponding to the sequences found associated with BEB and TSI samples.

Histograms of lengths of sequences obtained by merging overlapping $k$-mers show ([Appendix 1---figure 8](#app1fig8){ref-type="fig"}, [Appendix 1---figure 9](#app1fig9){ref-type="fig"}) peaks at 61 bp which is the maximum length corresponding to a single SNP for $k$-mer size of 31. We also see drops off after 98 bp in all cases providing evidence for multinucleotide mutations (MNMs) ([@bib12]) since this is the maximum sequence length we can get when $k$-mers of size 31 are assembled with minimum overlap of 24.

HAWK reveals sequences not in the human reference genome {#s3-4}
--------------------------------------------------------

As [Hawk]{.smallcaps} is an alignment free method for mapping associations, it is able to find associations in regions that are not in the human reference genome, hg38. The analysis resulted in 94,795 and 66,051 sequences of lengths up to 2,666 bp and 12,467 bp associated with YRI and TSI samples respectively that did not map to the human reference genome. Similarly BEB-TSI comparison yielded 19,584 and 18,508 sequences with maximum lengths of 1761 bp and 2149 bp associated with BEB and TSI respectively.

We found that few of the sequences enriched for in TSI samples, with lengths up to 12kbp and 2kbp in comparisons with YRI and BEB respectively, mapped to the Epstein--Barr virus (EBV) genome, strain B95-8 \[GenBank: V01555.2\]. EBV strain B95-8 was used to transform B cells into lymphoblastoid cell lines (LCLs) in the 1000 Genomes Project and was shown to be a contaminant in the data ([@bib40]).

10.7554/eLife.32920.006

###### Summary of sequences not in the human reference genome.

[Table 2](#table2){ref-type="table"} shows summary of sequences associated with different populations that did not map to the human reference genome (hg38) or to the Epstein-Barr virus genome.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Population   Population compared to   Total no. sequences   No. sequences with length$\geq$1000bp   Total length in\      No. sequences with length$\geq$200bp   Total length in sequences with length$\geq$200bp
                                                                                                      sequences with\                                              
                                                                                                      length$\geq$1000 bp                                          
  ------------ ------------------------ --------------------- --------------------------------------- --------------------- -------------------------------------- --------------------------------------------------
  YRI          TSI                      94,795                41                                      59,956                478                                    225,426

  TSI          YRI                      66,051                10                                      13,896                184                                    77,383

  BEB          TSI                      19,584                3                                       3835                  75                                     33,954

  TSI          BEB                      18,508                2                                       2105                  81                                     28,134
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

[Table 2](#table2){ref-type="table"} summarizes the sequences that could not be mapped to either the human reference genome or the Epstein-Barr virus genome using Bowtie2. Although an exhaustive analysis of all remaining sequences using BLAST is difficult, we find sequences associated with YRI that do not map to the human reference genome (hg38) with high score but upon running BLAST aligned to other sequences from human (for example to \[GenBank: AC205876.2\] and some other sequences reported ([@bib23]). We also find sequences with no significant BLAST hits to human genomic sequences, some of which have hits to closely related species. Similarly, we find sequences associated with TSI aligning to human sequences such as \[GenBank: AC217954.1\] not in the reference. Although there are much fewer long sequences obtained in the BEB-TSI comparison, we find sequences longer than 1kbp associated with each population with no BLAST hit.

Differential prevalence of variants in genes linked to CVDs in BEB-TSI comparison {#s3-5}
---------------------------------------------------------------------------------

We noted that cardiovascular diseases (CVD) are a leading cause of mortality in Bangladesh and age standardized death rates from CVDs in Bangladesh is higher compared to Italy (see [@bib49]). Moreover, South Asians have high rates of acute myocardial infarction (MI) or heart failure at younger ages compared to other populations and ([@bib11]; [@bib18]) revealed that in several countries migrants from South Asia have higher death rates from coronary heart disease (CHD) at younger ages compared with the local population and according to the [Interheart]{.smallcaps} Study, the mean age of MI among the poeple from Bangladesh is considerably lower than non-South Asians and the lowest among South Asians ([@bib50]; [@bib41]). This motivated us to explore probable underlying genetic causes.

The sequences of significant association with the BEB sample were aligned to RefSeq mRNAs and the ones mapping to genes linked to CVDs ([@bib20]) were analyzed. It is worth noting that the sites were obtained through a comparison of BEB and TSI samples and CVD status of the individuals were unknown. We explored whether any of the sites found due to population difference could potentially contribute towards increased mortality from CVDs in BEB. The sites listed are included as they are in genes known to be linked to CVDs but they are not highly ranked among all sites of difference between BEB and TSI.

[Table 3](#table3){ref-type="table"} shows non-synonymous variants in such genes that are significantly more common in the BEB sample compared to the TSI sample. It is worth mentioning that the 'C' allele at the SNP site, rs1042034 in the gene *Apolipoprotein B (ApoB)* has been associated with increased levels of HDL cholesterol and decreased levels of triglycerides ([@bib45]) in individuals of European descent but individuals with the 'CC' genotype have been reported to have higher risk of CVDs in an analysis of the data from the Framingham Heart Study ([@bib24]). Distribution of rs1042034 alleles in various populations is shown in [Appendix 1---figure 10](#app1fig10){ref-type="fig"} generated using the geography of genetic variants browser ([@bib28]). The SNP rs676210 has also been associated with a number of traits ([@bib30]; [@bib4]). Both alleles of higher prevalence in BEB at those sites have been found to be common in familial hypercholesterolemia patients in Taiwan ([@bib5]). On the other hand, prevalence of the risk allele, 'T' at rs3184504 in the gene *SH2B3* is higher in TSI samples compared to BEB samples.
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###### Variants in genes linked to cardiovascular diseases.

Variants in genes linked to cardiovascular diseases found to be significantly more common in BEB samples compared to TSI samples. The (%) values denote fraction of individuals in the sample with the allele present. The p-values and % values are averaged over $k$-mers constituting the associated sequences.

  Gene      SN id        Variant type           Allele   p-value                  %BEB     %TSI
  --------- ------------ ---------------------- -------- ------------------------ -------- --------
  APOB      rs2302515    Missense               C        1.30$\times 10^{- 12}$   29.29%   8.37%
  APOB      rs676210     Missense               A        7.73$\times 10^{- 25}$   72.93%   33.08%
  APOB      rs1042034    Missense               C        2.28$\times 10^{- 23}$   68.67%   31.91%
  CYP11B2   rs4545       Missense               T        1.31$\times 10^{- 28}$   31.33%   0.91%
  CYP11B1   rs4534       Missense               T        9.36$\times 10^{- 36}$   33.00%   0.91%
  WNK4      rs2290041    Missense               T        1.53$\times 10^{- 14}$   13.24%   0.47%
  WNK4      rs55781437   Missense               T        1.30$\times 10^{- 12}$   15.21%   0.91%
  SLC12A3   rs2289113    Missense               T        7.40$\times 10^{- 13}$   8.14%    0.00%
  SCNN1A    rs10849447   Missense               C        8.67$\times 10^{- 12}$   62.88%   39.92%
  ABO       \-           4 bp (CTGT) deletion   \-       1.17$\times 10^{- 13}$   29.15%   10.55%
  ABO       rs8176741    Missense               A        2.06$\times 10^{- 16}$   27.70%   8.45%
  SH2B3     rs3184504    Missense               C        8.22$\times 10^{- 23}$   92.88%   63.87%
  RAI1      rs3803763    Missense               C        1.32$\times 10^{- 12}$   75.86%   51.17%
  RAI1      rs11649804   Missense               A        1.95$\times 10^{- 19}$   81.57%   52.79%

We also observe a number of sites in the gene *Titin (TTN)* of differential allele frequencies in BEB and TSI samples ([Appendix 1---table 1](#app1table1){ref-type="table"}). However, *TTN* codes for the largest known protein and although truncating mutations in *TTN* are known to cause dilated cardiomyopathy \[([@bib14]; [@bib47]; [@bib38])\], no such effect of other kinds of mutations are known.

Detection and correction for confounding factors {#s3-6}
------------------------------------------------

To check whether population structure can be detected from $k$-mer data we randomly sampled approximately one thousandth of $k$-mers that appear in between 1% and 99% of the YRI and TSI datasets in the 1000 genomes project yielding 3,483,820 distinct $k$-mers and ran principal components analysis (PCA) on them. [Figure 4(a)](#fig4){ref-type="fig"} shows plots of the first two principal components of the individuals. Although the clusters generated are not as clearly separated as in the case with PCA run on variant calls obtained from the 1000 genomes project, shown in [Appendix 1---figure 11](#app1fig11){ref-type="fig"}, possibly due to varying sequencing coverage and batch effects in the $k$-mer counts, we observe that the first two principal components together completely separates the two populations. The first principal component correlates with sequencing depth indicated by size of the circles in the figure with the second principal component primarily separating the populations.

![Detection and correction for population stratification in YRI-TSI dataset.\
(**a**) Plots of first two principal components for YRI and TSI individuals from the 1000 genomes project. The PCA was run on a binary matrix indicating presence or absence of 3,483,820 randomly chosen $k$-mers present in between 1% and 99% of the samples. The colors indicate population and sizes of circles are proportional to sequencing depth. (**b**) $- log_{10}$(adjusted p-values) are plotted against $- log_{10}$(unadjusted p-values) where adjusted p-values are calculated by fitting logistic regression models to predict population identity from $k$-mer counts adjusting for population stratification, total number of $k$-mers per sample and gender of individuals whereas unadjusted p-values are the p-values obtained using likelihood ratio test of $k$-mer counts assuming Poisson distributions.](elife-32920-fig4){#fig4}

We then fit logistic regression models to predict population identities using first two principal components, total number of $k$-mers in each sample and gender of individuals along with $k$-mer counts and obtain ANOVA p-values of the $k$-mer counts using $\chi^{2}$-tests. Total number of $k$-mers was included in the model as sequencing biases such as the GC content bias are known which may lead to false positives if the cases and controls are sequenced at different sequencing depths while the genders of individuals are included to prevent false positives for $k$-mers from X and Y chromosomes in case of sex imbalance in cases and controls. Negative ten based logarithms of unadjusted p-values were calculated using a Poisson distribution based likelihood ratio test and are shown against those of adjusted p-values for 2,113,327 randomly chosen $k$-mers with statistically significant unadjusted p-values in [Figure 4(b)](#fig4){ref-type="fig"}. It shows that all of the $- log_{10}$(adjusted p-values) are close to zero which is expected since the first two principal components together completely separate the populations. QQ plot of adjusted p-values of 56,119 randomly chosen $k$-mers is shown in [Appendix 1---figure 11(c)](#app1fig11){ref-type="fig"}. [Appendix 1---figure 11(d)](#app1fig11){ref-type="fig"} shows that only the first two principal components provide substantial adjustment in p-values for this dataset indicating sequencing depth and sex are not significant confounders while QQ plot for unadjusted p-values obtained from logistic regression is shown in [Appendix 1---figure 11(b)](#app1fig11){ref-type="fig"}.

We also performed simulation experiments to test whether associations can be detected after correcting for confounding factors. We set a $k$-mer as present in a YRI individual with probability $p$ and in a TSI individual with probability $1 - p$ and counts were simulated using total numbers of $k$-mers in the samples assuming Poisson distribution. The individuals with the $k$-mer were randomly assigned to cases according to penetrance values and the rest were assigned to controls. A p-value was then computed as above correcting for population stratification and other confounders and tested for significance. The process was repeated 1000 times for a particular $p$ and penetrance and repeated for other values. The fraction of runs association was detected are shown in [Appendix 1---figure 12](#app1fig12){ref-type="fig"}. We observe that with logistic regression based test that has less power compared to Poisson distribution based likelihood ratio test, associations can be detected with small sample sizes such as present ones under various conditions. For example, if 80% of case individuals are YRI, associations can be detected in all trials if penetrance is 100% and about 80% trials when it is 80%.

Association mapping ampicillin resistance in *E. coli* {#s3-7}
------------------------------------------------------

Finally we applied [Hawk]{.smallcaps} to map association to ampicillin resistance in *E. coli* using a dataset described in ([@bib7]). It contains short reads from 241 strains of *E. coli*, 189 of which were resistant to ampicillin and the remaining 52 were sensitive. We ran [Hawk]{.smallcaps} on 176,284,643 $k$-mers obtained from the whole genome sequencing reads, first computing p-values using likelihood ratio test assuming Poisson distribution and then adjusting p-values using first ten principal components and total number of $k$-mers per sample for the top 200,000 $k$-mers associated with cases and controls. 5047 of the $k$-mers associated with cases passed Bonferroni correction while none of the ones associated with controls did.

The $k$-mers passing Bonferroni correction were assembled using ABySS resulting in 16 sequences associated with cases. Upon running BLAST on these sequences we found hits to *Escherichia coli* strain DTU-1 genome \[GenBank: CP026612.1\], *Escherichia coli* strain KBN10P04869 plasmid pKBN10P04869A sequence \[GenBank: CP026474.1\] as well as other sequences. We then mapped the $k$-mers found significant using these two sequences as the references to obtain their locations within them. Manhattan plots of the positions thus obtained and $- log_{10}$(adjusted p-values) of the corresponding $k$-mers are shown in [Figure 5](#fig5){ref-type="fig"}. We found that the strongest associations are within the $\beta$*-lactamase TEM-1 (blaTEM-1*) gene which is known to confer resistance to ampicillin (also detected by \[[@bib7]\]) and just upstream of that. We also noted some other hits within the *E. coli* chromosome.

![Manhattan plots for association mapping of ampicillin resistance in *E.*\
*coli* using $k$-mers. Manhattan plots showing $- log_{10}$(adjusted p-values) of $k$-mers found significantly associated with ampicillin resistance and their start positions in (**a**) *Escherichia coli* strain DTU-1 genome and (**b**) plasmid pKBN10P04869A sequence. The vertical lines denote start positions of $\beta$-lactamase TEM-1 gene, the presence of which is known to confer resistance to ampicillin.\
10.7554/eLife.32920.010Figure 5---source data 1.Source data for [Figure 5a](#fig5){ref-type="fig"}.Source file contains $k$-mer sequences, corresponding p-values and their positions in *Escherichia coli* strain DTU-1 genome in SAM format.\
10.7554/eLife.32920.011Figure 5---source data 2.Source data for [Figure 5b](#fig5){ref-type="fig"}.Source file contains $k$-mer sequences, corresponding p-values and their positions in plasmid pKBN10P04869A sequence in SAM format.](elife-32920-fig5){#fig5}

QQ plot of the p-values obtained is shown in [Appendix 1---figure 13(a)](#app1fig13){ref-type="fig"}. It may be noted that for large number of $k$-mers, that are part of the $\beta$*-lactamase TEM-1 (blaTEM-1*) gene or are in linkage disequilibrium with it, the null is not true which results in deviations from the diagonal line. However, majority of the points are close to the origin which can be seen from the cumulative distribution of p-values in [Appendix 1---figure 6(b)](#app1fig6){ref-type="fig"}.

([@bib7]) performed an association study of ampicillin resistance using multiple approaches - SNP calling and imputations, gene presence or absence through whole genome assembly and gene finding as well as a $k$-mer based method. Their gene presence or absence approach yielded $\beta$*-lactamase TEM-1 (blaTEM-1*) as the top hit while the best $k$-mer within the causal gene found by them was of rank 6. However, neither of the approaches are likely to scale to large genomes. We also followed a more conventional approach where first the reads were mapped using Bowtie 2 ([@bib25]) to the reference strain CFT073 \[GenBank: AE014075.1\], the same reference used by ([@bib7]). We also included plasmid pKBN10P04869A sequence \[GenBank: CP026474.1\] in the reference as it includes the $\beta$*-lactamase TEM-1 (blaTEM-1*) gene. Freebayes ([@bib10]) was then used to simultaneously call variants in all the strains. We finally tested each variant for association to ampicillin resistance using Eigenstrat ([@bib35]) using first ten principal components to correct for confounders. This approach resulted in no hits with genome wide significance and Manhattan plots of the variants and their $- log_{10}$(p-values) are shown in [Appendix 1---figure 14](#app1fig14){ref-type="fig"}.

Discussion {#s4}
==========

In this paper, we presented an alignment free method for association mapping from whole genome sequencing reads. It is based on finding $k$-mers that appear significantly more times in one set of samples compared to the other and then locally assembling those $k$-mers. Since this method does not require a reference genome, it is applicable to association studies of organisms with no or incomplete reference genome. Even for human our method is advantageous as it can map associations in regions not in the reference or where variant calling is difficult.

We tested our method by applying it to data from the 1000 genomes project and comparing the results with the results obtained using the genotypes called by the project as well as using simulated data. We observe that more than 80% of the sites found using genotype calls are covered by some sequence obtained by our method while also mapping associations to regions not in the reference and in repetitive areas. Moreover, simulations suggest tests based on $k$-mer counts have more power than those based on presence and absence of alleles.

Breakdown analysis of the sequences found in pairwise comparison of YRI, TSI and BEB, TSI samples reveals that this approach allows mapping associations to SNPs, indels, structural and copy number variations through the same pipeline. In addition we find 2--4% of associated sequences are not present in the human reference genome some of which are longer than 1kbp. The YRI, TSI comparison yields almost 60kbp sequence associated with the YRI samples in sequences of length greater than 1kbp alone. This indicates populations around the world have regions in the genome not present in the reference emphasizing the importance of a reference free approach.

We explored variants in genes linked to cardiovascular diseases in the BEB, TSI comparison as South Asians are known to have a higher rate of mortality from heart diseases compared to many other populations. We find a number of non-synonymous mutations in those genes are more common in the BEB samples in comparison to the TSI ones underscoring the importance of association studies in diverse populations. The SNP rs1042034 in the gene *Apolipoprotein B (ApoB)* merits particular mention as the CC genotype at that site has been associated with higher risk of CVDs.

We also outlined an approach to uncover population stratification, a known confounder in association studies, from $k$-mer data and correct for it and other confounders in our $k$-mer based association mapping pipeline. Application of the pipeline to map associations to ampicillin resistance in *E. coli* lead to hits to a gene, the presence of which is known to provide the resistance.

The results on simulated data, real data from the 1000 genomes project and *E. coli* datasets provide a proof of principle of this approach and motivate extension of this method to quantitative phenotypes and modeling of randomness of counts in population stratification detection and correction of confounder steps and then application to association studies of disease phenotypes in humans and other organisms.
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Finding differential $k$-mers in association studies {#s7}
====================================================

10.7554/eLife.32920.013

We consider the case where we have $s_{1}$ and $s_{2}$ samples from two populations. We observe a specific $k$-mer $k_{1,1},\ldots,k_{1,s_{1}}$ and $k_{2,1},\ldots,k_{2,s_{2}}$ times in the samples from two populations and total $k$-mer counts in the samples are given by $n_{1,1},\ldots,n_{1,s_{1}}$ and $n_{2,1},\ldots,n_{2,s_{2}}$. We assume that the $k$-mer counts are Poisson distributed with rate $\theta_{1}$ and $\theta_{2}$ in the two populations where the $\theta$'s can be interpreted as quantities proportional to the average number of times the $k$-mer appears in the two populations. The null hypothesis is $H_{0}:\theta_{1} = \theta_{2} = \theta$ and the alternate hypothesis is $H_{1}:\theta_{1} \neq \theta_{2}$

We test the null using likelihood ratio test for nested models. The likelihood ratio is given by$$\Lambda = \frac{sup\left\{ L\left( \theta_{1},\theta_{2} \right) \right\}}{sup\left\{ L\left( \theta,\theta \right) \right\}}$$where$$L\left( \theta_{1},\theta_{2} \right) = \prod\limits_{i = 1}^{s_{1}}\,\frac{e^{- \theta_{1}n_{1,i}}\left( \theta_{1}n_{1,i} \right)^{k_{1,i}}}{k_{1,i}!}\prod\limits_{i = 1}^{s_{2}}\,\frac{e^{- \theta_{2}n_{2,i}}\left( \theta_{2}n_{2,i} \right)^{k_{2,i}}}{k_{2,i}!}$$and$$L\left( \theta \right) = \prod\limits_{i = 1}^{s_{1}}\,\frac{e^{- \theta n_{1,i}}\left( \theta n_{1,i} \right)^{k_{1,i}}}{k_{1,i}!}\prod\limits_{i = 1}^{s_{2}}\,\frac{e^{- \theta n_{2,i}}\left( \theta n_{2,i} \right)^{k_{2,i}}}{k_{2,i}!}.$$

$L\left( \theta_{1},\theta_{2} \right)$ is maximized at ${\hat{\theta}}_{1} = \frac{\sum\limits_{i = 1}^{s_{1}}\ k_{1,i}}{\sum\limits_{i = 1}^{s_{1}}\ n_{1,i}}$, ${\hat{\theta}}_{2} = \frac{\sum\limits_{i = 1}^{s_{2}}\ k_{2,i}}{\sum\limits_{i = 1}^{s_{2}}\ n_{2,i}}$ and $L\left( \theta \right)$ is maximized at $\hat{\theta} = \frac{\sum\limits_{i = 1}^{s_{1}}\ k_{1,i} + \sum\limits_{i = 1}^{s_{2}}\ k_{2,i}}{\sum\limits_{i = 1}^{s_{1}}\ n_{1,i} + \sum\limits_{i = 1}^{s_{2}}\ n_{2,i}}$. Therefore,$$\Lambda = \frac{L\left( {{\hat{\theta}}_{1},{\hat{\theta}}_{2}} \right)}{L\left( {\hat{\theta},\hat{\theta}} \right)}.$$

Since the null model is a special case of the alternate model, $2ln\Lambda$ is approximately chi-squared distributed with one degree of freedom.([@bib48]; [@bib15]; [@bib16])

We note that the test statistic stays the same if the likelihood values are computed by pooling together the counts in samples from two populations that is$$L\left( \theta_{1},\theta_{2} \right) = \frac{e^{- \theta_{1}N_{1}}\left( \theta_{1}N_{1} \right)^{K_{1}}}{K_{1}!}\frac{e^{- \theta_{2}N_{2}}\left( \theta_{2}N_{2} \right)^{K_{2}}}{K_{2}!}$$and$$L\left( \theta \right) = \frac{e^{- \theta N_{1}}\left( \theta N_{1} \right)^{K_{1}}}{K_{1}!}\frac{e^{- \theta N_{2}}\left( \theta N_{2} \right)^{K_{2}}}{K_{2}!}$$where $\sum_{i = 1}^{s_{1}}\, k_{1,i} = K_{1}$, $\sum_{i = 1}^{s_{2}}\, k_{2,i} = K_{2}$, $\sum_{i = 1}^{s_{1}}\, n_{1,i} = N_{1}$, and $\sum_{i = 1}^{s_{2}}\, n_{2,i} = N_{2}$.

For each $k$-mer in the data, we compute the statistic as described above and obtain a P-value using $\chi_{1}^{2}$ distribution. The P-values are then corrected for multiple testing using Bonferroni correction.

![QQ plots of p-values.\
QQ plots of p-values calculated using likelihood ratio test with Poisson and negative binomial distributions for (a) simulated data and (b) real data from the 1000 genomes project. The simulation was performed by sampling $200$ values from a negative binomial distribution with number of failures fixed at $1$ million and a uniformly chosen success probability between $0$ and $0.01$. Half of the samples were assigned to cases and others were assigned to controls. Then p-values were computed using likelihood ratio tests with Poisson and negative binomial distributions. The process was repeated $100,000$ times and QQ plot was generated. Similarly p-values were computed for counts of $56,119$ randomly chosen $k$-mers from YRI and TSI populations from the 1000 genomes project.](elife-32920-app1-fig1){#app1fig1}

Power Calculation {#s8}
=================

To evaluate the theoretical power of the test, we fixed the number of times a $k$-mer is present in control samples at 0, obtained the minimum $k$-mer count in case samples required to obtain a p-value less than significant threshold after Bonferroni correction and calculated the probability of observing at least that count in case samples for varying total $k$-mer coverage of cases (number of case samples $\times$$k$-mer coverage per sample). The results are plotted in [Appendix 1---figure 2](#app1fig2){ref-type="fig"} for different total number of tests.

![Power for different $k$-mer coverages.\
The figure shows power to detect a $k$-mer present in all case samples and no control sample against total $k$-mer coverage of cases using Bonferroni correction for different number of total tests for p-value=0.05.](elife-32920-app1-fig2){#app1fig2}

We have also performed a simulation similar to the one in [@bib26]. Ratio of cases to controls was set at 0.5. Then for a fixed minor allele frequency (MAF) and different odds ratios (OR) and total number of samples, the number of case samples with the variant was determined by solving a quadratic equation and the probabilities of samples being case or control with and without the variant were calculated. Cases and controls were then sampled 100 times using those probabilities. The fraction of times the p-value obtained was below the significance level, after Bonferroni correction for 1 million tests, are then plotted against the number of samples in [Appendix 1---figure 3](#app1fig3){ref-type="fig"}.

![Power vs number of samples.\
Figures show power to detect a $k$-mer at MAF = 0.16 and different odds ratios for per sample $k$-mer coverage of (**a**) five and (**b**) two after Bonferroni correction for 1 million tests.](elife-32920-app1-fig3){#app1fig3}

![Comparison of powers of Poisson LRT and logistic regression based tests.\
Figures show power to detect a $k$-mer by Poisson based likelihood ratio test, logistic regression based tests using $k$-mer counts and presence and absence of $k$-mers with number of allele copies in controls fixed at (**a**), (**b**) 0 and (**c**), (**d**) 1. Simulation was performed by randomly choosing case individuals with specified number of copies of an allele according to varying probability. $k$-mer counts were then generated according to Poisson distribution and detection of association was checked after Bonferroni correction for 1 million tests. The process was repeated 100 times for each set of parameters. Number of cases and number of controls were fixed at 100.](elife-32920-app1-fig4){#app1fig4}

Verification with simulated E. coli data {#s9}
========================================

The simulation with *E. coli* genome ($\sim$4.6 million bp) was performed by first introducing 100 single base changes, 100 indels of random lengths less than 10 bp and 100 indels of random lengths between 100 and 1000 bp at random locations. Then different number of controls and cases were generated using wgsim of SAMtools ([@bib27]) introducing more mutations with default parameters and 300000 paired end reads of length 70 ($\sim$5x $k$-mer coverage) were generated with sequencing error rate of 0.01.

The sensitivity and specificity analysis was done by aligning the sequences generated by HAWK using Bowtie 2 ([@bib25]) and checking for overlap with mutation locations with in-house scripts.

![Sensitivity with simulated *E. coli* data.\
The figure shows sensitivity for varying number of case and control samples for different types of mutations. Sensitivity is defined as the percentage of differing nucleotides that are covered by a sequence. All of the sequences covered some location of mutation.](elife-32920-app1-fig5){#app1fig5}

Testing for significant genotypes {#s10}
=================================

Consider a site with two alleles. Let $n_{1,0},n_{1,1},n_{1,2}$ be the number of individuals with 0,1 and 2 copies of the minor allele respectively in the sample from population one and $n_{2,0},n_{2,1},n_{2,2}$ are the corresponding ones from population 2. Let $p_{1}$ and $p_{2}$ be the minor allele frequencies in the two populations and $N_{1}$ and $N_{2}$ be the number of samples. The null hypothesis is $H_{0}:p_{1} = p_{2} = p$ and the alternate hypothesis is $H_{0}:p_{1} \neq p_{2}$

We test the null using likelihood ratio test for nested models. The likelihood ratio is given by$$\Lambda = \frac{sup\left\{ L\left( p_{1},p_{2} \right) \right\}}{sup\left\{ L\left( p,p \right) \right\}}$$where under random mating$$\begin{matrix}
{L\left( {p_{1},p_{2}} \right)} & {= \begin{pmatrix}
N_{1} \\
{n_{1,0},n_{1,1},n_{1,2}} \\
\end{pmatrix}\left( {1 - p_{1}} \right)^{2n_{1,0}}\left( {2p_{1}\left( {1 - p_{1}} \right)} \right)^{n_{1,1}}p_{1}^{2n_{1,2}}} \\
 & {\,\,\,\,\,\,\begin{pmatrix}
N_{2} \\
{n_{2,0},n_{2,1},n_{2,2}} \\
\end{pmatrix}\left( {1 - p_{2}} \right)^{2n_{2,0}}\left( {2p_{2}\left( {1 - p_{2}} \right)} \right)^{n_{2,1}}p_{2}^{2n_{2,2}}} \\
\end{matrix}$$and$$\begin{matrix}
{L\left( p \right)} & {= \begin{pmatrix}
N_{1} \\
{n_{1,0},n_{1,1},n_{1,2}} \\
\end{pmatrix}\left( {1 - p} \right)^{2n_{1,0}}\left( {2p\left( {1 - p} \right)} \right)^{n_{1,1}}p^{2n_{1,2}}} \\
 & {\,\,\,\,\,\,\,\begin{pmatrix}
N_{2} \\
{n_{2,0},n_{2,1},n_{2,2}} \\
\end{pmatrix}\left( {1 - p} \right)^{2n_{2,0}}\left( {2p\left( {1 - p} \right)} \right)^{n_{2,1}}p^{2n_{2,2}}.} \\
\end{matrix}$$

$L\left( p_{1},p_{2} \right)$ is maximized at ${\hat{p}}_{1} = \frac{n_{1,1} + 2n_{1,2}}{2N_{1}}$, ${\hat{p}}_{2} = \frac{n_{2,1} + 2n_{2,2}}{2N_{2}}$ and $L\left( p \right)$ is maximized at $\hat{p} = \frac{n_{1,1} + 2n_{1,2} + n_{2,1} + 2n_{2,2}}{2N_{1} + 2N_{2}}$. Therefore,$$\Lambda = \frac{L\left( {{\hat{p}}_{1},{\hat{p}}_{2}} \right)}{L\left( {\hat{p},\hat{p}} \right)}.$$

Since the null model is a special case of the alternate model, $2ln\Lambda$ is approximately chi-squared distributed with one degree of freedom.

For each SNP site in the data, we compute the statistic as described above and obtain a p-value using $\chi_{1}^{2}$ distribution. The p-values are then corrected for multiple testing using Bonferroni correction.

Intersection analysis using 1000 genomes data {#s11}
=============================================

For the intersection analysis we used data from 87 YRI individuals and 98 TSI individuals for which both sequencing reads and genotype calls were available. The [Hawk]{.smallcaps} pipeline was run using a $k$-mer size of 31. The assembly was using ABySS ([@bib43]). The sequences were aligned to the human reference genome version GRCh37 using Bowtie2. Each of the genotypes called by the 1000 genomes project was then tested for association with populations using the approach described in the previous section. The extent of intersection of the loci found using two methods was then determined using BEDtools ([@bib36]).

![QQ plot and cumulative distributions of p-values.\
The figures show (a) QQ plot and (b) cumulative distributions of $- log_{10}$(p-values) for observed p-values in the comparison of YRI and TSI populations from the 1000 genomes project and p-values expected if the null is true.](elife-32920-app1-fig6){#app1fig6}

Breakdown analysis {#s12}
==================

The types of variants corresponding to sequences found using the [Hawk]{.smallcaps} pipeline were estimated by mapping them to the human reference genome version hg38 using Bowtie2 and using following properties.

-   **Unmapped:** The sequences that were not mapped to the reference using Bowtie2.

-   **Multimapped:** The sequences with multiple mappings. These may be due to copy number variations or sequence variation in repetitive regions.

-   **Indels:** The sequences that mapped to the reference with one or more indels.

-   **Multiple SNPs/Structural:** The maximum length of a sequence due to a single SNP with 31-mer is 61. Sequences with length greater than 61 were assigned this label.

-   **SNPs:** All other sequences.

![Breakdown of types of variations in BEB-TSI comparison.\
(**a**) Bar plots showing breakdown of 529,287 and 462,122 sequences associated with BEB and TSI samples respectively. The 'Multiple SNPs/Structural' entries correspond to sequences of length greater than 61, the maximum length of a sequence due to a single SNP with $k$-mer size of 31 and 'SNPs' correspond to sequences of maximum length of 61. (**b**) Numbers of sequences with alignments to hg38, RefSeq mRNAs and Ensembl exons and coding regions.](elife-32920-app1-fig7){#app1fig7}

![Histograms of sequence lengths in YRI-TSI comparison.\
Figures show sections of histograms of lengths of sequences associated with (**a**, **c**) YRI and (**b**, **d**) TSI in comparison of YRI and TSI samples. Figures (**a**), (**b**) show peaks at 61, the maximum length corresponding to a single SNP with $k$-mer size of 31. Figures (**c**), (**d**) show drop off after 98 which is the maximum length corresponding to two close-by SNPs as 31-mers were assembled using a minimum overlap of 24.](elife-32920-app1-fig8){#app1fig8}

![Histograms of sequence lengths in BEB-TSI comparison.\
Figures show sections of histograms of lengths of sequences associated with (**a**,** c**) BEB and (**b**,** d**) TSI in comparison of BEB and TSI samples. Figures (**a**), (**b**) show peaks at 61, the maximum length corresponding to a single SNP with $k$-mer size of 31. Figures (**c**), (**d**) show drop off after 98 which is the maximum length corresponding to two close-by SNPs as 31-mers were assembled using a minimum overlap of 24.](elife-32920-app1-fig9){#app1fig9}

Probing for variants of interest {#s13}
================================

We searched for well known variants and other variants of potential biological interest by aligning sequences to RefSeq mRNAs using Bowtie2 and then looking up gene names from RefSeq mRNA identifiers using the UCSC Table Browser ([@bib19]). Variants of interest were then further explored by running BLAT ([@bib22]) on the UCSC Human Genome Browser ([@bib21]).

![Distribution of the SNP rs1042034 alleles in 1000 genomes populations.\
Plot obtained from the Geography of Genetic Variants Browser showing distribution of alleles at the SNP site rs1042034 revealing the 'C' allele is more prevalent in South, Southeast and East Asian populations compared to populations from other parts of the world.](elife-32920-app1-fig10){#app1fig10}

![Detection and correction for population stratification in YRI-TSI dataset.\
(**a**) Plots of first two principal components for YRI and TSI individuals where the PCA was run on variants called in the 1000 genomes project. QQ plots of ANOVA $\chi^{2}$ p-values of $k$-mer counts computed by running logistic regression (**b**) without adjustment, (**c**) adjusted using first two principal components obtained from $k$-mer counts, total number of $k$-mers and sex of individuals, (**d**) adjusted using only first two principal components.](elife-32920-app1-fig11){#app1fig11}

![Detection of association after correcting for confounders.\
A $k$-mer (allele) is considered to be present in a YRI individual with probability $p$ and in a TSI individual with probability $1 - p$ and counts are simulated using total numbers of $k$-mers in the samples assuming Poisson distribution. The individuals with the $k$-mer are randomly assigned to cases according to a penetrance value and the rest are assigned to controls. A p-value is then computed using logistic regression to predict phenotype from the counts correcting for population stratification, total number of $k$-mers per sample and gender of individuals from the 1000 genomes data. The process is repeated 1000 times for a particular $p$ and penetrance and fraction of runs where the p-value passed the Bonferroni threshold is plotted. The process is repeated for various probabilities and penetrance.](elife-32920-app1-fig12){#app1fig12}

![QQ plot and cumulative distributions of p-values.\
The figures show (**a**) QQ plot and (**b**) cumulative distributions of $- log_{10}$(p-values) for observed p-values in association mapping of ampicillin resistance in *E. coli* and p-values expected if the null is true.](elife-32920-app1-fig13){#app1fig13}

![Manhattan plots for association mapping of ampicillin resistance in *E. coli* using conventional approach.\
Manhattan plots showing $- log_{10}$(p-values) of SNPs and their positions in (**a**) *Escherichia coli* strain CFT073 genome and (**b**) plasmid pKBN10P04869A sequence. The vertical lines denote start positions of $\beta$*-lactamase TEM-1* gene, the presence of which is known to confer resistance to ampicillin. The horizontal lines denote Bonferroni threshold of $0.05/361293$.](elife-32920-app1-fig14){#app1fig14}
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###### Variants in *Titin* of differential prevalence in BEB-TSI comparison.

Variants in *Titin*, a gene linked to cardiovascular diseases, that were found to be significantly more common in BEB samples compared to TSI samples. The (%) values denote fraction of individuals in the sample with the allele present. The p-values and % values are averaged over $k$-mers constituting the associated sequences.

  Gene   SNP id                 Variant type      Allele   p-value                  %BEB     %TSI
  ------ ---------------------- ----------------- -------- ------------------------ -------- --------
  TTN    rs9808377              Missense          G        1.70$\times 10^{- 15}$   66.44%   41.91%
  TTN    rs62621236             Missense          G        2.33$\times 10^{- 16}$   27.70%   5.72%
  TTN    rs2291311              Missense          C        1.06$\times 10^{- 11}$   25.77%   7.77%
  TTN    rs16866425             Missense          C        8.19$\times 10^{- 12}$   21.73%   2.73%
  TTN    rs4894048              Missense          T        2.00$\times 10^{- 23}$   22.65%   2.26%
  TTN    rs13398235             Intron/missense   A        2.04$\times 10^{- 13}$   41.00%   17.40%
  TTN    rs11888217             Intron/missense   T        4.18$\times 10^{- 13}$   27.25%   4.55%
  TTN    rs10164753             Missense          T        3.69$\times 10^{- 13}$   28.48%   6.19%
  TTN    rs10497520             Missense          T        1.66$\times 10^{- 23}$   54.76%   18.86%
  TTN    rs2627037              Missense          A        6.99$\times 10^{- 13}$   25.06%   4.72%
  TTN    rs1001238              Missense          C        1.66$\times 10^{- 17}$   64.66%   38.21%
  TTN    rs3731746              Missense          A        1.26$\times 10^{- 14}$   50.72%   30.21%
  TTN    rs17355446             Intron/missense   A        3.31$\times 10^{- 11}$   15.44%   1.11%
  TTN    rs2042996              Missense          A        1.03$\times 10^{- 17}$   71.41%   35.87%
  TTN    rs747122               Missense          T        1.59$\times 10^{- 11}$   28.57%   7.24%
  TTN    rs1560221${}^{\ast}$   Synonymous        G        1.11$\times 10^{- 22}$   70.71%   34.66%
  TTN    rs16866406             Missense          A        2.17$\times 10^{- 12}$   35.60%   17.51%
  TTN    rs4894028              Missense          T        2.58$\times 10^{- 13}$   27.54%   6.89%
  TTN    \-                     Insertion         T        1.09$\times 10^{- 12}$   34.11%   8.59%
  TTN    rs3829747              Missense          T        4.72$\times 10^{- 12}$   37.55%   20.30%
  TTN    rs2291310              Missense          C        2.18$\times 10^{- 20}$   36.63%   8.04%
  TTN    rs2042995              Intron/Missense   C        7.83$\times 10^{- 12}$   56.32%   31.64%
  TTN    rs3829746              Missense          C        5.30$\times 10^{- 29}$   75.94%   37.60%
  TTN    rs744426               Missense          A        1.36$\times 10^{- 13}$   37.15%   18.92%
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Association Mapping from Sequencing Reads using *k*-mers\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Detlef Weigel as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Casey S Greene (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The paper describes a method and associated software (HAWK) that performs association mapping on sequencing data without the use of read alignment and variant calling. The method tests if *k*-mers are differentially represented in the reads from cases vs. controls, and concatenates overlapping *k*-mers to find out longer sequences are associated with the trait of interest. The method is particularly well suited to detecting associations with structural variants, since it avoids the problem of SV calling, which is currently challenging with current methods.

Overall, there was much enthusiasm for the work, but there were serious concerns regarding how the authors would account for population structure. This will need to be thoroughly addressed in a revision.

Essential revisions:

1\) Demonstrate that the method is robust to problems of population structure.

2\) Statistical problem: to test if *k*-mers are differentially represented in cases vs. controls, the authors do a simple two-sample Poisson comparison using likelihood ratio test. This makes the implicit assumption that the read counts are Poisson distributed and the Poisson rates are constant in cases and in controls. The latter assumption is generally problematic for read count data, as biological differences can create additional variations of read counts. Please show empirical evidence that the counts are Poisson, and indicate what could go wrong if they are not.

It is known in RNA-seq data, for example, that read counts from multiple samples cannot be adequately modeled by a Poisson distribution, and a negative binomial distribution is used to model \"overdispersion\" (some relevant papers are edgeR (Small-sample estimation of negative binomial dispersion, with applications to SAGE data, Robinson & Smith, Biostatistics, 2008) and WASP (PMID: 26366987)).

It is not entirely clear that using negative binomial (NB) would solve the problem in this case, as the underlying Poisson rates may be discrete. For instance, suppose the association signal is driven by a deletion (CNV). Each individual either has the deletion or not. NB makes the assumption that the rate follows a gamma distribution. The authors should show the signal is not driven by overdispersion or confounders. At the minimum, they should have a QQ plot, which shows that for most *k*-mers, there is no association.

3\) A related problem is the possible confounders. For example, if cases and controls have different coverage, and representation of *k*-mers somehow depends on coverage (GC content is correlated with coverage, for example), one could imagine that this may create some false associations.

4\) The validation of the method is inadequate. The experiment of classifying population ancestry is a quite artificial -- few people will do this kind of analysis. What is much more relevant is application of the method on real sequencing data of some complex phenotype. The authors did do it on a CVD dataset, but only superficially. They applied it only on genes known to be linked to CVD, for example, and it\'s unclear how the results compare with the alternative approach. To really demonstrate the benefits of HAWK, they should apply it to the full data, and evaluate the results more deeply. How do the results compare with standard GWAS? Any new associations? Can these new associations by validated? Do we learn any biology?

5\) The authors state that Cortex (Iqbal et al.) is not suited to a large number of individuals (Introduction, third paragraph). Please explain why this is the case. A comparison with HAWK would help to motivate their approach.

6\) Iqbal et al. say that \"Current assembly methods also typically ignore pre-existing information, such as a reference sequence or known variants. Although variant discovery should not be biased by such information, neither should this information be discarded.\" The authors should comment on this with respect to their approach.

7\) For the comparison between HAWK and traditional genotype GWAS (subsection "Verification with 1000 genomes data"), restrict the analysis to only SNPs, i.e. to variants that a normal GWAS is meant to capture. Then we can see the power difference afforded by Poisson and access to counts vs genotype calls. Also, include the use of dosages, a softer version of a hard variant calls. If the false positive rate is well-controlled here (provide quantile plots of p-values), and you are well-powered, then the much-harder-to-verify claims about finding structural variants are better supported.

8\) The authors should discuss the error rate they are interested in and why, and then explain what an appropriate error measure would be. For example, it seems that Storey et al.\'s *q*-values may be more appropriate (Bonferroni is overly conservative).

9\) In the comparison between HAWK and more conventional approaches, were the SNP calls used in the conventional approach based on the same data that HAWK had access to? If not, it\'s not really a fair comparison. Also, add in what happens if you use dosage calls.

10\) Include explanation of all the ways HAWK might lead to false positives, how likely they are to occur, and what can be done to find out if they are happening.

11\) HAWK appears only applicable to case-control, and not quantitative traits. This should be mentioned in the Abstract, and also more directly in the Introduction. The authors should explain how HAWK could be applied to quantitative traits (and ideally demonstrate it).

12\) Define the scope where HAWK is to be applied more carefully than \"sequencing data\". Please provide empirical support using real data for any claims (so, if it applies to RNA-Seq data, provide RNA-Seq support). The current results only appear to support whole genome sequencing use cases.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for submitting your article \"Association Mapping from Sequencing Reads using *k*-mers\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Detlef Weigel as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Casey S Greene (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Essential revisions:

1\) The CVD study seems very odd. The authors use BEB or TSI as response variables, and do association, instead of using CVD status (i.e. cases or controls). Since BEB and TSI are obviously different in population ancestry, the resulting *k*-mers would mostly reflect ancestry-specific markers. Indeed, in Table 3, for several variants, the difference between the frequencies of BEB and TSI groups are so large that they unlikely result from their disease effects. The authors show only results from genes already linked to CVD. It\'s not clear at all if these genes are ranked high in their findings, had they analyzed all genes. As such, it is almost impossible to interpret the results here -- whether it\'s due to population difference or disease association.

2\) In the *E. coli*. analysis: this is more like a true association study. Application to *E. coli* instead of human is a bit odd though. Other than that, if one uses traditional procedure of variant calling and association testing, will the same gene(s) be found? The authors need to demonstrate that their method adds something new.

3\) \"We agree that deviations from the Poisson assumption are possible, and this motivated us to perform the conservative Bonferroni correction and then assemble *k*-mers into larger sequences, providing an approach to discarding false positives\".

To appease the concern about the distributional assumption, it is not really sufficient to state that you are using a conservative type 1 error control. First, because that\'s not really a sensible way to fix the potential problem (albeit if it is the only practical one then I can accept it). Second, because who\'s to say if Boneferroni (or any method X) is conservative enough to outweigh potential false positive of a wrongly specified model? One would at least have to specifically demonstrate that.

Also, it would be good, as a baseline, to use an expensive negative binomial test to see how much better things would be if you could afford to do that. Otherwise we don\'t have a good sense of the cost of assuming Poisson (if any). Additionally, if you did negative binomial with a less conservative measure than Bonferroni, we\'d have still an even better sense of how bad the assumptions of your approach are. (Which is not to say one shouldn\'t use it for practical reasons). At the very least, it would be good to see some kind of further justification that Poisson is reasonable (maybe it is in there and I missed it).

4\) \"We then perform principal components analysis (PCA) on the matrix\".

How does this compare to doing a \"standard\" genetics PCA on the same samples? Which would you expect to be better, and for what reason? It would be nice to see some sort of head-to-head to get a sense of how different they are.

5\) \"We ﬁt a logistic regression model involving potential confounders and *k*-mers counts\".

\"involving\"? What precisely does this mean? Not clear what you did from this sentence. More importantly, it looks like you are here abandoning the fundamental part of HAWK, the Poisson testing, in this (population confounding) setting, and instead using standard GWAS techniques on the *k*-mer counts instead of on SNPs? If so, this should be expanded on and explained, and the cost in power discussed; if there is no cost in power, then why not use just that method instead of HAWK? In fact, it would be good to see a head-to-head comparison of this logistic regression approach with HAWK, when there is no confounding. This section needs more explicit description of what you are doing, why you are doing it, and what the pros and cons are.

6\) \"We then ﬁt logistic regression models to predict population identities using ﬁrst two principal components, total number of *k*-mers in each sample and gender of individuals along with *k*-mer counts and obtain ANOVA p-values of the *k*-mer counts using χ^2^-tests\"

You need to expand conceptually what is going on here. Why do you need the genders here? And why the total *k*-mer counts? Why not just the PCA? What are you trying to demonstrate exactly? Do you want to show that the PCs by themselves correct for confounding? Are you saying that gender is also a confounder here? If so, why? And if so, how would you account for it or other necessary covariates in your Poisson model? Please expand the thought process here.

7\) \"We observed that the ﬁrst two principal components separate the two populations and the ﬁrst principal component correlates with sequencing depth indicated by size of the circles in the ﬁgure\".

It seems that *only* PC2 is separating the populations; PC1 is most certainly not. Did you remove the mean from your data? PCA is a low rank approximation to the covariance matrix, and thus if you don\'t remove the mean, you don\'t really have a covariance matrix, and the first PCA will then just capture the mean, which may be what you are seeing here. When you say with \"sequencing depth\", specifically what sequencing depth do you mean here? Maybe this is related to the issue of the mean. (If this is hidden to you by using software, then it is trivial do implement from scratch in order to achieve full clarity.)

8\) \"We then performed simulation experiments to test whether associations can be detected after correcting for confounding factors. \[...\] The fraction of runs association was detected are shown in Appendix 1 Figure 9\"

You do this experiment, you have a plot in the appendix, but you fail to tell the reader what the results/take-home message are for it in the main text. Please add this.

9\) \"It shows that all of the −log~10~(adjusted p-values) are close to zero which is expected since the ﬁrst two principal components separate the populations\"

Please draw a QQ plot for the adjusted p-values so we can see just how calibrated thing are. I\'d also like to see QQ plots for the distribution of p-values in your simulations in general and on the real data analyses (both for population trait and otherwise).

10.7554/eLife.32920.033

Author response

> Essential revisions:
>
> 1\) Demonstrate that the method is robust to problems of population structure.

We have shown that population stratification can be inferred from *k*-mer data and that population stratification and other confounders can be used to adjust p-values. We have added subsections titled "Detecting population structure" and "Correcting for population stratification and other confounders" in the Materials and methods section and "Detection and correction for confounding factors" in the Results section. These describe our approach. We have also provided some validation results.

> 2\) Statistical problem: to test if k-mers are differentially represented in cases vs. controls, the authors do a simple two-sample Poisson comparison using likelihood ratio test. This makes the implicit assumption that the read counts are Poisson distributed and the Poisson rates are constant in cases and in controls. The latter assumption is generally problematic for read count data, as biological differences can create additional variations of read counts. Please show empirical evidence that the counts are Poisson, and indicate what could go wrong if they are not.
>
> It is known in RNA-seq data, for example, that read counts from multiple samples cannot be adequately modeled by a Poisson distribution, and a negative binomial distribution is used to model \"overdispersion\" (some relevant papers are edgeR (Small-sample estimation of negative binomial dispersion, with applications to SAGE data, Robinson & Smith, Biostatistics, 2008) and WASP (PMID: 26366987)).
>
> It is not entirely clear that using negative binomial (NB) would solve the problem in this case, as the underlying Poisson rates may be discrete. For instance, suppose the association signal is driven by a deletion (CNV). Each individual either has the deletion or not. NB makes the assumption that the rate follows a gamma distribution. The authors should show the signal is not driven by overdispersion or confounders. At the minimum, they should have a QQ plot, which shows that for most k-mers, there is no association.

Our rationale behind the Poisson assumption has been explained in the subsection "Finding significant *k*-mers". This assumption also has a computational advantage, allowing us to compute p-values quickly compared to negative binomial distribution based models which would require an iterative process. We agree that deviations from the Poisson assumption are possible, and this motivated us to perform the conservative Bonferroni correction and then assemble *k*-mers into larger sequences, providing an approach to discarding false positives. We also report fractions of individuals in groups with corresponding *k*-mers present for specific variants highlighted in the paper. Furthermore, the top hits eventually go through another step of adjustment for confounders. We have added the CDF of p-values in the YRI-TSI comparison which shows that for most *k*-mers p-values are not highly significant.

> 3\) A related problem is the possible confounders. For example, if cases and controls have different coverage, and representation of k-mers somehow depends on coverage (GC content is correlated with coverage, for example), one could imagine that this may create some false associations.

To address the problem of potential false associations due to different coverage, we propose to include total number of *k*-mers per sample in our confounder correction step explained in "Correcting for population stratification and other confounders" in Materials and methods and "Detection and correction for confounding factors" in Results.

> 4\) The validation of the method is inadequate. The experiment of classifying population ancestry is a quite artificial -- few people will do this kind of analysis. What is much more relevant is application of the method on real sequencing data of some complex phenotype. The authors did do it on a CVD dataset, but only superficially. They applied it only on genes known to be linked to CVD, for example, and it\'s unclear how the results compare with the alternative approach. To really demonstrate the benefits of HAWK, they should apply it to the full data, and evaluate the results more deeply. How do the results compare with standard GWAS? Any new associations? Can these new associations by validated? Do we learn any biology?

The objective of the association mapping with population identity as the phenotype was to check whether associations of diverse types of variants can be captured using *k*-mers in a setting not confounded by population structure. We have subsequently proposed an approach to correct for population stratification and other potential confounders and applied it to data to map ampicillin resistance in *E. coli* and updated the manuscript. We find hits to a gene known to confer the said resistance.

> 5\) The authors state that Cortex (Iqbal et al.) is not suited to a large number of individuals (Introduction, third paragraph). Please explain why this is the case. A comparison with HAWK would help to motivate their approach.

We have provided an explanation in the third paragraph of the Introduction.

> 6\) Iqbal et al. say that \"Current assembly methods also typically ignore pre-existing information, such as a reference sequence or known variants. Although variant discovery should not be biased by such information, neither should this information be discarded.\" The authors should comment on this with respect to their approach.

A major motivation of our approach is to allow association mapping in organisms with no or incomplete reference genome and not be biased by reference genome in variant calling. An intriguing question is at what stage we can better utilize reference genomes? One answer may be when assembling *k*-mers. We have commented on this in the sixth paragraph of the Introduction.

> 7\) For the comparison between HAWK and traditional genotype GWAS (subsection "Verification with 1000 genomes data"), restrict the analysis to only SNPs, i.e. to variants that a normal GWAS is meant to capture. Then we can see the power difference afforded by Poisson and access to counts vs genotype calls. Also, include the use of dosages, a softer version of a hard variant calls. If the false positive rate is well-controlled here (provide quantile plots of p-values), and you are well-powered, then the much-harder-to-verify claims about finding structural variants are better supported.

A limitation of our approach is it doesn't allow us to consider only one type of variant. While a single SNP can lead to sequences of maximum length of 61, there are often multiple SNPs nearby making restricting analysis to SNPs difficult. Presence of *k*-mers due to structural variants and contaminants make a straightforward comparison between the approaches hard. Hence we resorted to simulation. We stress that the major motivation of our approach is to allow association mapping without a reference genome. The power issue was discussed to partly explain the larger number hits found by *k*-mer based approach.

> 8\) The authors should discuss the error rate they are interested in and why, and then explain what an appropriate error measure would be. For example, it seems that Storey et al.\'s q-values may be more appropriate (Bonferroni is overly conservative).

We have used the conservative Bonferroni correction specifically because it is conservative and thus can ameliorate deviation from the Poisson assumption. We have added an explanation in "Finding significant *k*-mers".

> 9\) In the comparison between HAWK and more conventional approaches, were the SNP calls used in the conventional approach based on the same data that HAWK had access to? If not, it\'s not really a fair comparison. Also, add in what happens if you use dosage calls.

Yes, we used the same set of reads used by the 1000 genomes project to call variants.

> 10\) Include explanation of all the ways HAWK might lead to false positives, how likely they are to occur, and what can be done to find out if they are happening.

We have listed possible reasons behind false positives in the subsection "Correcting for population stratification and other confounders" and discussed an approach to deal with them.

> 11\) HAWK appears only applicable to case-control, and not quantitative traits. This should be mentioned in the Abstract, and also more directly in the Introduction. The authors should explain how HAWK could be applied to quantitative traits (and ideally demonstrate it).

We have mentioned it in the Abstract and the Introduction. We have mentioned how we may extend this to quantitative phenotypes at the ends of the subsections "Finding significant *k*-mers" and "Correcting for population stratification and other confounders".

> 12\) Define the scope where HAWK is to be applied more carefully than \"sequencing data\". Please provide empirical support using real data for any claims (so, if it applies to RNA-Seq data, provide RNA-Seq support). The current results only appear to support whole genome sequencing use cases.

We have applied our method to whole-genome sequencing data so far. The manuscript has been updated to reflect that.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> Essential revisions:
>
> 1\) The CVD study seems very odd. The authors use BEB or TSI as response variables, and do association, instead of using CVD status (i.e. cases or controls). Since BEB and TSI are obviously different in population ancestry, the resulting k-mers would mostly reflect ancestry-specific markers. Indeed, in Table 3, for several variants, the difference between the frequencies of BEB and TSI groups are so large that they unlikely result from their disease effects. The authors show only results from genes already linked to CVD. It\'s not clear at all if these genes are ranked high in their findings, had they analyzed all genes. As such, it is almost impossible to interpret the results here -- whether it\'s due to population difference or disease association.

Since the sites were obtained using population identity and not CVD status, they are due to population difference. We merely wanted to explore whether any of those could potentially contribute to higher mortality from CVDs in BEB. The listed sites are not the highest ranked ones and are included as they are in genes known to be linked to CVDs. We have provided clarification in the second paragraph of the subsection "Differential prevalence of variants in genes linked to CVDs in BEB-TSI comparison". We feel that insights gained from such unconventional methods may help researchers to narrow down on specific variants and study their effects.

> 2\) In the E. coli. analysis: this is more like a true association study. Application to E. coli instead of human is a bit odd though. Other than that, if one uses traditional procedure of variant calling and association testing, will the same gene(s) be found? The authors need to demonstrate that their method adds something new.

We have performed a conventional association study, presented the results in Figure 14 in the appendix and discussed our findings and limitations of such approaches in the last paragraph of the subsection "Association mapping ampicillin resistance in *E. coli*".

> 3\) \"We agree that deviations from the Poisson assumption are possible, and this motivated us to perform the conservative Bonferroni correction and then assemble k-mers into larger sequences, providing an approach to discarding false positives\".
>
> To appease the concern about the distributional assumption, it is not really sufficient to state that you are using a conservative type 1 error control. First, because that\'s not really a sensible way to fix the potential problem (albeit if it is the only practical one then I can accept it). Second, because who\'s to say if Boneferroni (or any method X) is conservative enough to outweigh potential false positive of a wrongly specified model? One would at least have to specifically demonstrate that.
>
> Also, it would be good, as a baseline, to use an expensive negative binomial test to see how much better things would be if you could afford to do that. Otherwise we don\'t have a good sense of the cost of assuming Poisson (if any). Additionally, if you did negative binomial with a less conservative measure than Bonferroni, we\'d have still an even better sense of how bad the assumptions of your approach are. (Which is not to say one shouldn\'t use it for practical reasons). At the very least, it would be good to see some kind of further justification that Poisson is reasonable (maybe it is in there and I missed it).

We have presented our reasoning behind the Poisson assumption in the first paragraph of the subsection "Finding significant *k*-mers". Earlier we had meant to say, albeit not quantitatively, that when there is deviation from the Poisson assumption, a series of measures is likely to reduce the number of false positives.

We have performed a simulation where data is simulated from negative binomial distributions and p-values were then calculated using likelihood ratio tests for both Poisson and negative binomial distributions. The results are in Appendix 1 Figure 1 along with p-values calculated in the same way on some real data. The results do not indicate that p-values calculated assuming Poisson distribution is notably lower than those found using negative binomial distributions.

> 4\) \"We then perform principal components analysis (PCA) on the matrix\".
>
> How does this compare to doing a \"standard\" genetics PCA on the same samples? Which would you expect to be better, and for what reason? Would be nice to see some sort of head-to-head to get a sense of how different they are.

We have added a PCA plot obtained from variant calls in Appendix 1 Figure 11A and explained why those should be cleaner than PCA done with *k*-mer counts in the first paragraph of the subsection "Detection and correction for confounding factors".

> 5\) \"we ﬁt a logistic regression model involving potential confounders and k-mers counts\".
>
> \"involving\"? What precisely does this mean? Not clear what you did from this sentence. More importantly, it looks like you are here abandoning the fundamental part of HAWK, the Poisson testing, in this (population confounding) setting, and instead using standard GWAS techniques on the k-mer counts instead of on SNPs? If so, this should be expanded on and explained, and the cost in power discussed; if there is no cost in power, then why not use just that method instead of HAWK? In fact, it would be good to see a head-to-head comparison of this logistic regression approach with HAWK, when there is no confounding. This section needs more explicit description of what you are doing, why you are doing it, and what the pros and cons are.

We have rewritten this part to clarify things. We actually think the fundamental part of HAWK is the testing of *k*-mers directly. The LRT based on Poisson lets us effectively and quickly test *k*-mers when there are no confounders and when there are confounders, lets us quickly filter *k*-mers out so that more computationally expensive tests can be performed on the rest. We have conducted simulations to assess loss in power and shown results in Appendix 1 Figure 4. We observe that there is cost in power. We leave designing tests taking into account stochasticity in *k*-mer counts which will hopefully improve power as future work. In any case, since we are fitting logistic regressions, it will be difficult to scale up to all the *k*-mers. The section has been expanded (subsection "Correcting for population stratification and other confounders").

> *6) \"We then ﬁt logistic regression models to predict population identities using ﬁrst two principal components, total number of k-mers in each sample and gender of individuals along with k-mer counts and obtain ANOVA p-values of the k-mer counts using* χ^2^-tests\".
>
> You need to expand conceptually what is going on here. Why do you need the genders here? And why the total k-mer counts? Why not just the PCA? What are you trying to demonstrate exactly? Do you want to show that the PCs by themselves correct for confounding? Are you saying that gender is also a confounder here? If so, why? And if so, how would you account for it or other necessary covariates in your Poisson model? Please expand the thought process here.

The genders of individuals are included to prevent false positives from *k*-mers from X and Y chromosomes in case of sex imbalance in cases and controls. Total number of *k*-mers was included in the model as sequencing biases such as the GC content bias are known which may lead to false positives if the cases and controls are sequenced at different sequencing depths. We have provided a detailed description (subsection "Detection and correction for confounding factors", second paragraph). These were included to illustrate that they could be confounders in some datasets. However, for this dataset first two PCs adequately adjust for confounders (Appendix 1 Figure 11D). So, gender is not a confounder here. The Poisson model is used when there is no significant confounding. When there are we perform a second phase of adjusting p-values using logistic regression.

> 7\) \"We observed that the ﬁrst two principal components separate the two populations and the ﬁrst principal component correlates with sequencing depth indicated by size of the circles in the ﬁgure\".
>
> It seems that only PC2 is separating the populations; PC1 is most certainly not. Did you remove the mean from your data? PCA is a low rank approximation to the covariance matrix, and thus if you don\'t remove the mean, you don\'t really have a covariance matrix, and the first PCA will then just capture the mean, which may be what you are seeing here. When you say with \"sequencing depth\", specifically what sequencing depth do you mean here? Maybe this is related to the issue of the mean. (If this is hidden to you by using software, then it is trivial do implement from scratch in order to achieve full clarity.)

We meant PC1 and PC2 together separates the populations. The mean was indeed removed from the data. The correlation between PC1 and sequencing depth i.e. average number of reads covering a base is possibly due to not getting reads from hard to sequence regions when the depth is low and may be due to other batch effects (sequencing depth is linked here to the sequencing platform used).

> 8\) \"We then performed simulation experiments to test whether associations can be detected after correcting for confounding factors. \[...\] The fraction of runs association was detected are shown in Appendix 1 Figure 9\".
>
> You do this experiment, you have a plot in the appendix, but you fail to tell the reader what the results/take-home message are for it in the main text. Please add this.

We have added a comment to summarize the plot in the last paragraph of the subsection "Detection and correction for confounding factors".

> 9\) \"It shows that all of the −log~10~(adjusted p-values) are close to zero which is expected since the ﬁrst two principal components separate the populations\".
>
> Please draw a QQ plot for the adjusted p-values so we can see just how calibrated thing are. I\'d also like to see QQ plots for the distribution of p-values in your simulations in general and on the real data analyses (both for population trait and otherwise).

We have added QQ plots for adjusted p-values for 1000 genomes (Appendix 1 Figure 10), QQ plots for Poisson LRT p-values for YRI-TSI comparison (Appendix 1 Figure 5), QQ plots for adjusted p-values *E. coli* ampicillin resistance association mapping (Appendix 1 Figure 12) among others.
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